/
Psychiatry
Anxiety
38
Pipeline Programs↗
131
Active Trials↗
50
Companies Involved↗
Anxiety is a moderately active landscape with 38 programs across 50 companies. The most active players are Otsuka, Johnson & Johnson. 2 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical31
Phase 11
Phase 24
Approved
No programs
Analysis
Trial Status
383
clinical trials
Completed204 · 53%
Recruiting62 · 16%
Not yet recruiting48 · 13%
Unknown status22 · 6%
Terminated19 · 5%
Active, not recruiting18 · 5%
Other10 · 3%
Clinical Trials
Trial Activity
383 trials
Efficacy of a Multisensory Audiovisual Entrainment Neurofeedback for Academic Anxiety Regulation and Divergent Thinking: A Randomized Controlled Trial Study
Recruiting·—·Preclinical·NCT07745335·240 enrolled
Grow With Grit: A Nurse-Led SBIRT Model for Early Anxiety Detection and School-Based Mental Health Intervention in Rural Youth
Recruiting·McLaughlin Research Institute for Biomedical Sciences, Inc.·Preclinical·NCT07766785·60 enrolled
Page 1 of 26
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)